Generative AI: FDA adcomm discusses performance evaluation, risk management for medical devices
Regulatory NewsJeff Craven
CDRHDigital health/SaMD/AIMedical DevicesProduct LifecycleRisk managementUnited StatesUS Food and Drug Administration (FDA)Regulatory NewsJeff CravenCDRHDigital health/SaMD/AIMedical DevicesProduct LifecycleRisk managementUnited StatesUS Food and Drug Administration (FDA)